Latest Insider Transactions at Fortress Biotech, Inc. (FBIO)
This section provides a real-time view of insider transactions for Fortress Biotech, Inc. (FBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Fortress Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Fortress Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 01
2022
|
J Jay Lobell Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+7.49%
|
-
|
Jan 01
2022
|
Jimmie Harvey Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+10.53%
|
-
|
Jan 01
2022
|
Kevin Lorenz Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+15.89%
|
-
|
Jan 01
2022
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,102,986
+8.21%
|
-
|
Jan 01
2022
|
Malcolm Hoenlein Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+9.33%
|
-
|
Jan 01
2022
|
Dov Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+11.75%
|
-
|
Jan 01
2022
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,102,986
+8.73%
|
-
|
Dec 28
2021
|
Dov Klein Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.76%
|
$10,000
$2.45 P/Share
|
Dec 01
2021
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.01%
|
$2,500
$2.42 P/Share
|
Nov 16
2021
|
Malcolm Hoenlein Director |
BUY
Other acquisition or disposition
|
Direct |
230
+0.05%
|
-
|
Nov 16
2021
|
Dov Klein Director |
BUY
Other acquisition or disposition
|
Direct |
230
+0.04%
|
-
|
Nov 16
2021
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Other acquisition or disposition
|
Direct |
4,619
+0.04%
|
-
|
Sep 30
2021
|
Malcolm Hoenlein Director |
BUY
Other acquisition or disposition
|
Direct |
406
+0.09%
|
-
|
Sep 30
2021
|
Dov Klein Director |
BUY
Other acquisition or disposition
|
Direct |
480
+0.07%
|
-
|
Sep 30
2021
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Other acquisition or disposition
|
Direct |
8,133
+0.08%
|
-
|
Sep 21
2021
|
Robyn Hunter Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,292
-14.72%
|
$84,876
$3.13 P/Share
|
Aug 05
2021
|
Dov Klein Director |
BUY
Other acquisition or disposition
|
Direct |
305
+0.05%
|
-
|
Jun 01
2021
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,297
+0.01%
|
$2,594
$2.31 P/Share
|
Mar 02
2021
|
Eric K Rowinsky Director |
SELL
Open market or private sale
|
Direct |
10,000
-1.37%
|
$40,000
$4.45 P/Share
|
Feb 19
2021
|
Eric K Rowinsky Director |
SELL
Open market or private sale
|
Direct |
8,000
-1.08%
|
$32,000
$4.31 P/Share
|
Feb 18
2021
|
Eric K Rowinsky Director |
SELL
Open market or private sale
|
Direct |
6,000
-0.81%
|
$24,000
$4.2 P/Share
|
Feb 16
2021
|
Eric K Rowinsky Director |
SELL
Open market or private sale
|
Direct |
2,000
-0.27%
|
$6,000
$3.86 P/Share
|
Feb 05
2021
|
Eric K Rowinsky Director |
SELL
Open market or private sale
|
Direct |
4,000
-0.53%
|
$12,000
$3.8 P/Share
|
Jan 01
2021
|
Jimmie Harvey Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+11.76%
|
-
|
Jan 01
2021
|
Malcolm Hoenlein Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+10.31%
|
-
|
Jan 01
2021
|
Dov Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+13.25%
|
-
|
Jan 01
2021
|
J Jay Lobell Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+8.09%
|
-
|
Jan 01
2021
|
Kevin Lorenz Director |
BUY
Open market or private purchase
|
Direct |
50,000
+18.9%
|
-
|
Jan 01
2021
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+11.76%
|
-
|
Jan 01
2021
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,030,339
+8.4%
|
-
|
Jan 01
2021
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,030,339
+9.01%
|
-
|
Dec 01
2020
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.01%
|
$2,500
$2.34 P/Share
|
Jun 01
2020
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,602
+0.02%
|
$1,602
$1.69 P/Share
|